Dr. Nicolas Bamat is a neonatologist and clinical investigator dedicated to improving outcomes for infants and families impacted by lung disease of prematurity. He is an Attending Physician in the Newborn and Infants Chronic Lung Disease Program at Children's Hospital of Philadelphia and an Assistant Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. His research program is focused on helping to identify safe and effective pharmacotherapies in neonatal lung disease. His current focus is on the use of furosemide in infants with bronchopulmonary dysplasia (BPD). In addition to his clinical training, Dr. Bamat obtained a Master of Science in Clinical Epidemiology (MSCE). He serves as an Associate Editor for Cochrane Neonatal, is an Executive Board Member for The International Society for Evidence-Based Neonatology (EBNEO), and leads the Pharmacology Working Group of the BPD Collaborative.